» Articles » PMID: 39712151

,'-Di-benzyl-ethyl-enedi-ammonium Dichloride

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

The isolation and crystalline structure of ,'-di-benzyl-ethyl-enedi-ammonium dichloride, CHN ·2Cl, is reported. This was obtained as an unintended product of an attempted Curtius rearrangement that involved benzyl-amine as one of the reagents and 1,2-di-chloro-ethane as the solvent. Part of a series of reactions of a course-based undergraduate research experience (CURE), this was not the intended reaction outcome. The goal of the course was to engage students as active participants in a laboratory experience which applies the foundational techniques of a synthetic organic laboratory, using the Curtius rearrangement as a tool for the assembly of medicinally significant scaffolds. The isolation of the title compound, -di-benzyl-ethyl-enedi-ammonium dichloride, the result of the 1,2-di-chloro-ethane solvent outcompeting the Curtius iso-cyanate inter-mediate in the reaction with the nucleophilic amine, confirms the importance of conducting research at the undergraduate level where the outcome is not predetermined. The solid-state structure of ,'-di-benzyl-ethyl-enedi-ammonium dichloride was found to feature an all- methyl-ene-ammonium backbone. Strong N-H⋯Cl hydrogen bonds and C-H⋯Cl inter-actions lead to a layered structure with pseudo-translational symmetry emulating a -centered setting. Different phenyl torsion angles at each end of the mol-ecule enable a more stable packing by allowing stronger hydrogen-bonding inter-actions, leading to a more ordered but lower symmetry and modulated structure in 2/.

References
1.
Ghosh A, Brindisi M, Sarkar A . The Curtius Rearrangement: Applications in Modern Drug Discovery and Medicinal Chemistry. ChemMedChem. 2018; 13(22):2351-2373. PMC: 6604631. DOI: 10.1002/cmdc.201800518. View

2.
Groom C, Bruno I, Lightfoot M, Ward S . The Cambridge Structural Database. Acta Crystallogr B Struct Sci Cryst Eng Mater. 2016; 72(Pt 2):171-9. PMC: 4822653. DOI: 10.1107/S2052520616003954. View

3.
Wang J, Tao Y, Feng J, Niu Y, Liu J, Huang Y . and evaluation of benzathine foscarnet microcrystals as a potential intravitreal drug depot. RSC Adv. 2022; 9(37):21318-21322. PMC: 9066022. DOI: 10.1039/c9ra03070k. View

4.
Krause L, Herbst-Irmer R, Sheldrick G, Stalke D . Comparison of silver and molybdenum microfocus X-ray sources for single-crystal structure determination. J Appl Crystallogr. 2015; 48(Pt 1):3-10. PMC: 4453166. DOI: 10.1107/S1600576714022985. View

5.
Macrae C, Sovago I, Cottrell S, Galek P, McCabe P, Pidcock E . : from visualization to analysis, design and prediction. J Appl Crystallogr. 2020; 53(Pt 1):226-235. PMC: 6998782. DOI: 10.1107/S1600576719014092. View